Ausgabe 3/2017
Inhalt (9 Artikel)
Current Opinion
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
Kevin A. Hay, Cameron J. Turtle
Leading Article
Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
Cristina Bianchi, Giuseppe Daniele, Angela Dardano, Roberto Miccoli, Stefano Del Prato
Therapy in Practice
Drug Therapy for Stable Angina Pectoris
Talla A. Rousan, Sunil T. Mathew, Udho Thadani
Review Article
Pharmacological Management of Chronic Pelvic Pain in Women
Erin T. Carey, Sara R. Till, Sawsan As-Sanie
Review Article
The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis
Gregory Heath, Archana Airody, Richard Peter Gale
Original Research Article
Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System
Jennifer B. Lai, Maxwell A. Witt, Mary Patricia Pauly, Joanna Ready, Michael Allerton, Suk Seo, David J. Witt
Adis Drug Evaluation
Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus
Karly P. Garnock-Jones
Adis Drug Evaluation
Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation
Hannah A. Blair, Gillian M. Keating